We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
NIO
NIO
$12.1B
| $197K | ﹤0.01% |
47,411
-1,601,840
| -97% | -$7.58M |
|
2427
Immunome
IMNM
$2.91B
| $194K | ﹤0.01% |
16,064
+4,129
| +35% | +$64.6K |
|
2428
Commercial Vehicle Group
CVGI
$134M
| $194K | ﹤0.01% |
39,663
+1,982
| +5% | +$11.2K |
|
2429
Hippo Holdings
HIPO
$856M
| $194K | ﹤0.01% |
+11,266
| New | +$214K |
|
2430
PMV Pharmaceuticals
PMVP
$65.6M
| $193K | ﹤0.01% |
118,917
+3,942
| +3% | +$7.11K |
|
|
PYCR
2431
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $192K | ﹤0.01% |
+15,290
| New | +$229K |
|
|
ELP
2432
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $192K | ﹤0.01% |
28,647
+8,618
| +43% | +$62K |
|
2433
Anavex Life Sciences
AVXL
$314M
| $191K | ﹤0.01% |
45,219
+26,821
| +146% | +$108K |
|
2434
Warby Parker
WRBY
$3.26B
| $186K | ﹤0.01% |
+11,559
| New | +$171K |
|
2435
Grindr
GRND
$2.91B
| $185K | ﹤0.01% |
15,075
+107
| +0.7% | +$1.07K |
|
|
HDSN
2436
Hudson Technologies
HDSN
$240M
| $184K | ﹤0.01% |
20,904
-16,025
| -43% | -$155K |
|
|
ASAI
2437
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $184K | ﹤0.01% |
19,738
+6,068
| +44% | +$75.2K |
|
2438
Avita Medical
RCEL
$235M
| $183K | ﹤0.01% |
23,065
-67,535
| -75% | -$642K |
|
|
THRD
2439
DELISTED
Third Harmonic Bio
THRD
| $183K | ﹤0.01% |
+14,043
| New | +$174K |
|
|
ENFN
2440
DELISTED
Enfusion, Inc.
ENFN
| $177K | ﹤0.01% |
20,819
-36,554
| -64% | -$334K |
|
2441
Tango Therapeutics
TNGX
$4.51B
| $177K | ﹤0.01% |
20,651
-30,323
| -59% | -$234K |
|
|
AVDX
2442
DELISTED
AvidXchange
AVDX
| $177K | ﹤0.01% |
14,658
-57,708
| -80% | -$659K |
|
2443
Prime Medicine
PRME
$571M
| $176K | ﹤0.01% |
+34,268
| New | +$208K |
|
2444
Geron
GERN
$949M
| $175K | ﹤0.01% |
+41,245
| New | +$161K |
|
|
ME
2445
DELISTED
23andMe Holding Co
ME
| $174K | ﹤0.01% |
22,211
+13,173
| +146% | +$126K |
|
2446
Marqeta
MQ
$1.62B
| $169K | ﹤0.01% |
7,701
+2,955
| +62% | +$65.1K |
|
2447
CoreCivic
CXW
$3.26B
| $168K | ﹤0.01% |
12,912
-2,135
| -14% | -$31.2K |
|
2448
Wave Life Sciences
WVE
$1.2B
| $167K | ﹤0.01% |
33,529
+6,973
| +26% | +$39.8K |
|
2449
Adicet Bio
ACET
$75.9M
| $165K | ﹤0.01% |
8,548
+7,070
| +478% | +$189K |
|
2450
AGNC Investment
AGNC
$12.8B
| $163K | ﹤0.01% |
+17,133
| New | +$164K |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.